Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 5-fluorouracil after microneedling for refractory stable vitiligo
IRCT20250121064470N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in Vitiligo, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Repigmentation. Started Sep 2024; status: completed.
02
Drugs
fluorouracil
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20250121064470N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250121064470N1.